Physician

Shanti K Neerukonda, M.D.

According to 2025 Medicare claims, Shanti Neerukonda, M.D. (NPI: 1740219807) practices cardiology in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is BIG BEND MEDICAL GROUP (NPI: 1811973282; TIN: 752841116) and primary practice location at 79761-4411. Neerukonda is affiliated with the CareMax Accountable Care Network, LLC (ACO ID: A5080) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Neerukonda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 425 traditional Medicare patients, billed 1,433 HCPCS/CPT codes, and received $129,951 in Medicare payments. The top billing code was 93351 (Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report). Part D data shows 3,783 prescription claims across 543 beneficiaries totaling $436,144 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 12 claims. Open Payments data shows 20 records totaling $457. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $354,208 to $129,951. In contrast, Part D prescription costs have risen steadily, from $301,771 to $436,144. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	949	4,723	$354,208
2016	880	4,196	$333,288
2017	830	3,645	$288,673
2018	756	2,817	$223,245
2019	719	2,719	$235,463
2020	553	1,676	$153,554
2021	552	1,946	$191,912
2022	531	1,900	$177,146
2023	477	1,488	$138,711
2024	425	1,433	$129,951

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	578	7,110	$301,771
2016	590	6,995	$294,674
2017	588	6,779	$315,538
2018	586	5,621	$274,724
2019	584	4,598	$334,175
2020	518	3,839	$438,177
2021	549	3,720	$393,995
2022	585	3,924	$438,031
2023	565	3,755	$444,974
2024	543	3,783	$436,144

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$1,988
2016	N/R	N/R	N/R
2017	N/R	12	$25,826
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93351	Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report	101	106	$155
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	39	39	$117
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	98	104	$96
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	63	76	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	342	793	$81

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	153	7,996	$149,415
Xarelto	Rivaroxaban	98	4,260	$74,910
Farxiga	Dapagliflozin Propanediol	47	1,980	$36,360
Multaq	Dronedarone Hcl	22	1,260	$30,608
Entresto	Sacubitril/Valsartan	27	1,275	$28,869

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$457	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shanti K. Neerukonda, M.D.?

Tedicare shows public-source Medicare data for Shanti K. Neerukonda, M.D. (NPI 1740219807), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shanti K. Neerukonda, M.D. have ACO affiliation data?

Shanti K. Neerukonda, M.D. is shown with ACO affiliation data for CareMax Accountable Care Network, LLC (MSSP, ACO ID A5080) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Shanti K. Neerukonda, M.D.?

Shanti K. Neerukonda, M.D. is linked to BIG BEND MEDICAL GROUP (billing NPI 1811973282) in the available physician profile data.

Does Shanti K. Neerukonda, M.D. have Open Payments data?

Shanti K. Neerukonda, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.